247 related articles for article (PubMed ID: 23370777)
1. Vaspin inhibits kallikrein 7 by serpin mechanism.
Heiker JT; Klöting N; Kovacs P; Kuettner EB; Sträter N; Schultz S; Kern M; Stumvoll M; Blüher M; Beck-Sickinger AG
Cell Mol Life Sci; 2013 Jul; 70(14):2569-83. PubMed ID: 23370777
[TBL] [Abstract][Full Text] [Related]
2. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of human vaspin (SERPINA12) and its impact on serpin activity, heparin binding and thermal stability.
Oertwig K; Ulbricht D; Hanke S; Pippel J; Bellmann-Sickert K; Sträter N; Heiker JT
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1188-1194. PubMed ID: 28668641
[TBL] [Abstract][Full Text] [Related]
4. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.
Heiker JT
J Pept Sci; 2014 May; 20(5):299-306. PubMed ID: 24596079
[TBL] [Abstract][Full Text] [Related]
5. Vaspin in obesity and diabetes: pathophysiological and clinical significance.
Blüher M
Endocrine; 2012 Apr; 41(2):176-82. PubMed ID: 22139797
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of cleaved vaspin (serpinA12).
Pippel J; Kuettner EB; Ulbricht D; Daberger J; Schultz S; Heiker JT; Sträter N
Biol Chem; 2016 Jan; 397(2):111-23. PubMed ID: 26529565
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
Ulbricht D; Tindall CA; Oertwig K; Hanke S; Sträter N; Heiker JT
Biol Chem; 2018 Sep; 399(9):1079-1084. PubMed ID: 29494334
[TBL] [Abstract][Full Text] [Related]
8. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.
Hida K; Wada J; Eguchi J; Zhang H; Baba M; Seida A; Hashimoto I; Okada T; Yasuhara A; Nakatsuka A; Shikata K; Hourai S; Futami J; Watanabe E; Matsuki Y; Hiramatsu R; Akagi S; Makino H; Kanwar YS
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10610-5. PubMed ID: 16030142
[TBL] [Abstract][Full Text] [Related]
9. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects.
Klöting N; Kovacs P; Kern M; Heiker JT; Fasshauer M; Schön MR; Stumvoll M; Beck-Sickinger AG; Blüher M
Diabetologia; 2011 Jul; 54(7):1819-23. PubMed ID: 21465327
[TBL] [Abstract][Full Text] [Related]
10. Membrane Phospholipids and Polyphosphates as Cofactors and Binding Molecules of SERPINA12 (vaspin).
Tindall CA; Dommel S; Riedl V; Ulbricht D; Hanke S; Sträter N; Heiker JT
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344508
[TBL] [Abstract][Full Text] [Related]
11. Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).
Ulbricht D; Oertwig K; Arnsburg K; Saalbach A; Pippel J; Sträter N; Heiker JT
J Biol Chem; 2017 Jan; 292(3):994-1004. PubMed ID: 27941022
[TBL] [Abstract][Full Text] [Related]
12. Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways.
Liu S; Li X; Wu Y; Duan R; Zhang J; Du F; Zhang Q; Li Y; Li N
PLoS One; 2017; 12(12):e0189722. PubMed ID: 29240812
[TBL] [Abstract][Full Text] [Related]
13. [Effect of different intensity exercise prescription on visceral adipose Vaspin gene, protein expression and plasma Vaspin concentration in aged obese rats].
Lin C; Bai Y; Sun M; Zhang H; Su M; Cui J; Song W; Wu L
Wei Sheng Yan Jiu; 2017 Jan; 46(1):70-77. PubMed ID: 29903155
[TBL] [Abstract][Full Text] [Related]
14. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
[TBL] [Abstract][Full Text] [Related]
15. Overexpressing high levels of human vaspin limits high fat diet-induced obesity and enhances energy expenditure in a transgenic mouse.
Rapöhn I; Elias I; Weiner J; Pujol A; Kehr S; Chadt A; Al-Hasani H; Burkhardt R; Klöting N; Stumvoll M; Bosch F; Kovacs P; Heiker JT; Breitfeld J
Front Endocrinol (Lausanne); 2023; 14():1146454. PubMed ID: 37152954
[TBL] [Abstract][Full Text] [Related]
16. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between vaspin concentration and insulin sensitivity in the visceral adipose tissue of young obese rats].
Gao FF; Liu GL; Zheng RX; Jiang LH; Bao PL
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jan; 15(1):71-4. PubMed ID: 23336174
[TBL] [Abstract][Full Text] [Related]
18. Vaspin: a novel serpin with insulin-sensitizing effects.
Wada J
Expert Opin Investig Drugs; 2008 Mar; 17(3):327-33. PubMed ID: 18321232
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of Vaspin Action - From Adipose Tissue to Skin and Bone, from Blood Vessels to the Brain.
Weiner J; Zieger K; Pippel J; Heiker JT
Adv Exp Med Biol; 2019; 1111():159-188. PubMed ID: 30051323
[TBL] [Abstract][Full Text] [Related]
20. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity.
Li Q; Chen R; Moriya J; Yamakawa J; Sumino H; Kanda T; Takahashi T
J Int Med Res; 2008; 36(4):625-9. PubMed ID: 18652756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
